In the last trading session, 21.31 million Omega Therapeutics Inc (NASDAQ:OMGA) shares changed hands as the company’s beta touched 1.62. With the company’s per share price at $0.16 changed hands at $0.01 or 3.83% during last session, the market valuation stood at $8.85M. OMGA’s last price was a discount, traded about -2687.5% off its 52-week high of $4.46. The share price had its 52-week low at $0.10, which suggests the last value was 37.5% up since then.
Analysts gave the Omega Therapeutics Inc (OMGA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended OMGA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Omega Therapeutics Inc (NASDAQ:OMGA) trade information
Instantly OMGA was in green as seen at the end of in last trading. With action -27.48%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -78.55%, with the 5-day performance at -27.48% in the red. However, in the 30-day time frame, Omega Therapeutics Inc (NASDAQ:OMGA) is -66.34% down.
The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need an upside of 98.22% from its current market value. According to analyst projections, OMGA’s forecast low is 7 with 11 as the target high. To hit the forecast high, the stock’s price needs a -6775.0% plunge from its current level, while the stock would need to soar -4275.0% for it to hit the projected low.
Omega Therapeutics Inc (OMGA) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -48.08%. The 2025 estimates are for Omega Therapeutics Inc earnings to decrease by -26.67%.
Omega Therapeutics Inc (NASDAQ:OMGA)’s Major holders
FMR LLC holds the second largest percentage of outstanding shares, with 11.3181% or 6.24 million shares worth $12.92 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund. With 1.97 shares estimated at $0.31 million under it, the former controlled 3.55% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 1.41% of the shares, roughly 779.1 shares worth around $0.12 million.
